GSK-3β pathway is involved in amphiregulin-induced resistance to vincristine therapy in oral squamous cell carcinoma
碩士 === 國立嘉義大學 === 生化科技學系研究所 === 106 === At present, oral cancer is ranked the fifth most common cancer in Taiwan. Of these, oral squamous cell carcinoma (OSCC) accounts for approximately 90% of oral cancers. Despite advances in surgery, radiotherapy, and chemotherapy, the long-term survival rates wi...
Main Authors: | Wen-Ling Li, 李汶鈴 |
---|---|
Other Authors: | Chen,Jui-Chieh |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/4p2q2r |
Similar Items
-
Functional studies of Amphiregulin in oral carcinogenesis
by: Kai-Ying Yang, et al.
Published: (2004) -
Molecular Mechanisms Involved in Modulating Invasiveness of Oral Squamous Cell Carcinoma
by: Shiou-Ling Jian, et al.
Published: (2013) -
Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma
by: Kwanghee Ahn, et al.
Published: (2019-05-01) -
Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate
by: Li Chen, et al.
Published: (2020-07-01) -
circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling
by: Xueting Hu, et al.
Published: (2019-11-01)